Oncobesity News Posts
GLP-1 RAs Reduce Suicidal Behavior in Adolescents
Study found a 33% drop in suicidal ideation and attempts, with effect lasting up to 3 years. Medscape Medical News
Does BMI Underestimate Breast Cancer Risk?
Hormone receptor stratification showed that differences in population-attributable risk fractions by body fat were only observed in hormone receptor–positive cases. Medscape Medical News
Two women talk about their diagnoses during breast cancer awareness month to inspire others
October is breast cancer awareness month and highlights a troubling increase of diagnoses in women under 50. Early Today’s Fredlyn Pierre Louis spoke with two women who wanted to share their stories to inspire others.
Statin therapy reduces radiation-induced cardiotoxicity in patients with breast cancer receiving radiotherapy
1. In a cohort of individuals with invasive ductal carcinoma (IDC) that underwent breast-conserving surgery (BCS) and adjuvant breast radiotherapy, the use of statins was associated with a decreased risk of major adverse cardiovascular events (MACE). 2. All statins were effective at reducing the risk of MACE; however, hydrophilic statins (specifically rosuvastatin and pravastatin) had
The post Statin therapy reduces radiation-induced cardiotoxicity in patients with breast cancer receiving radiotherapy first appeared on 2 Minute Medicine. Source: 2 Minute Medicine
Study suggests around 40% of postmenopausal hormone positive breast cancers are linked to excess body fat
Around 40% of postmenopausal hormone positive breast cancer cases may be linked to excess body fat, suggests Spanish research published online in the Journal of Epidemiology & Community Health.
Obesity Epidemic Peaked? FDA Reviews Menopause Drug; Metabolic Surgery and Cancer
(MedPage Today) — The obesity epidemic may be plateauing in the U.S.; this could be why. (Washington Post)
A cohort study of older adults with an initial fragility fracture showed that less than a third filled a prescription for anti-osteoporosis…
Distant Recurrence Risk in Early Breast Cancer on the Decline
(MedPage Today) — The long-term risk of distant recurrence for women with early breast cancer has declined significantly, a decades-long analysis of clinical trial data showed, largely a result of patients enrolling with lower-risk disease along…
FDA says compounding pharmacies can keep making weight-loss med tirzepatide, for now
Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. Food and Drug Administration revisits its Oct. 2 decision to remove the medicine from a national drug shortage list.
The importance of breast cancer screening
October is Breast Cancer Awareness Month. Breast cancer is the second-leading cause of cancer deaths in women across the U.S. And rates of the disease continue to climb, notably among younger women. A report from the American Cancer Society calculates that one in 50 women will develop invasive breast cancer by the age of 50.
Experimental drug RK-33 shows promise in treating breast cancer bone metastasis
In a new study led by Johns Hopkins Medicine, the drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast cancer bone metastasis). RK-33 was previously shown to help treat other types of cancer and viral illnesses.
Compounding pharmacies can resume making tirzepatide as FDA reconsiders shortage
The FDA said in a court filing late Friday that it would allow pharmacists to continue making compounded versions of tirzepatide as it reconsiders whether the drug is in shortage.
Study Suggests No Suicide Signal in Teens Prescribed GLP-1 Agonists
(MedPage Today) — Treatment with GLP-1 receptor agonists was associated with lower risks of suicidal ideation or attempts in adolescents with obesity compared with those who were treated with lifestyle interventions, a retrospective cohort study…
GLP-1 weight-loss meds won’t raise teens’ suicide risk, may even lower it
As with any new drug, parents and doctors may worry that the use of GLP-1 weight-loss meds by children and teens might raise psychiatric risks, including the risk for suicide and suicidal thoughts.
New way to kill cancer cells could lead to longer lasting protection for people with breast cancer
Killing breast cancer cells in a way that trains the immune system to recognize and destroy residual cancer cells could offer longer lasting protection to people with the disease.
Jill Martin urges awareness of breast cancer genetic testing on ‘Football Night in America’
TODAY contributor Jill Martin was diagnosed Stage 2 breast cancer in 2023 after she learned she had a BRCA gene mutation, which increases a woman’s risk of developing breast cancer by 60-90%. Had she not been tested for the mutation, her cancer could’ve progressed further, and Jill, now cancer-free, may have had a very different prognosis. Jill urged viewers to learn whether they should undergo genetic testing for breast cancer ahead of the Giants-Bengals game on Oct. 13’s ‘Football Nigh
How to decide which breast cancer surgery is right for you
Women diagnosed with breast cancer are almost immediately confronted with treatment decisions. If a surgical oncologist gave a choice between a lumpectomy and a mastectomy to remove a tumor, that’s often because either option will lead to a similar long-term health outcome.
Cheap Ozempic knock-offs have risen in popularity — but are they safe?
As prices for Ozempic have risen in recent months, many people may be seeking cheaper alternatives for managing diabetes or weight loss. Dr. Brett Osborn and Dr. Sue Decotiis warn of potential risks.
Novel procedure combined with semaglutide may eliminate insulin dependency in type 2 diabetes
Groundbreaking research presented at UEG Week 2024 reveals a promising new treatment strategy for type 2 diabetes (T2D) that could significantly reduce or even eliminate the need for insulin therapy.
‘I’m a radiologist — to reduce breast cancer risk, eat these 5 foods and follow these healthy habits’
Fox News medical contributor Dr. Nicole Saphier appeared on “Fox & Friends” on Sunday to discuss the rising risk of breast cancer — and specific foods and habits that can help reduce it.
Kristen Dahlgren, Miranda McKeon share their breast cancer journey
Two breast cancer survivors, former NBC Correspondent Kristen Dahlgren and actor Miranda McKeon, join TODAY to talk about their experiences with breast cancer and the race for a vaccine for metastatic breast cancer.
Dense breasts can make it harder to spot cancer on a mammogram
A new U.S. rule requires mammography centers to inform women about their breast density
Doctor answers common breast cancer, mammogram questions
According to breastcancer.org, one in eight women in the U.S. will develop breast cancer at some point in their lifetime. However, the type is considered one of the most curable cancers if caught early. Chief of breast surgery at New York Presbyterian Medical Center Dr. Roshni Rao answers common questions this Breast Cancer Awareness Month.
Combination therapy shows promise against triple-negative breast cancer
GLP-1 drugs like Ozempic may protect brain health, several studies show
YouTube content can help some people cope with breast cancer diagnosis, Spanish study finds
A study by the University of the Basque Country (UPV/EHU) has identified the most relevant YouTube videos on breast cancer and the concerns of the people who post comments. The study is published in the journal Profesional de la información.
Next-gen weight loss drugs will have fewer side effects than Ozempic, pharma CEO says
Zealand Pharma CEO Adam Steensberg said Friday that the company is working on a next-generation weight loss drug that’s designed to work differently from those currently on the market and with the potential for fewer side effects.Read more…
Metabolic-Bariatric Surgery Reduces Pancreatic Cancer Risk
Effect appeared more pronounced among those with type 2 diabetes. Medscape Medical News
This Breast Cancer Ribbon Has a Different Take on Pink. Here’s What It Means
Landmarks around the world will light up in its colors for Breast Cancer Awareness Month.
Breast cancer patient says new type of chemo saved her life: ‘I am thriving’
A medical clinic in Scottsdale, Arizona, offers an alternative, personalized form of chemotherapy designed to target cancer cells without harming healthy cells. A woman says it saved her life.
PI3K Inhibitor Wins FDA Approval for Advanced Breast Cancer
(MedPage Today) — The FDA approved the PI3K-pathway inhibitor inavolisib (Itovebi) for use in combination with palbociclib (Ibrance) and fulvestrant to treat locally advanced, PIK3CA-mutated, hormone receptor (HR)-positive/HER2-negative breast…
Increasing amount of breast cancer-specific death due to stage 1, 2 disease
Patients with stage I/II breast cancers have excellent prognosis, but account for more than 60 percent of breast cancer-specific death (BCSD) because of their large absolute volumes, according to a study published online Sept. 30 in the Journal of the National Cancer Institute.
Tirzepatide reduces obstructive sleep apnea symptoms and associated risks
1. In this randomized controlled trial, in patients with both moderate-severe obstructive sleep apnea (OSA) and obesity, it was found that tirzepatide treatment reduced the occurrence of apneas and hypopneas. 2. Tirzepatide treatment was associated with reduced body weight and sleep apnea-associated cardiovascular risk factors. Evidence Rating Level: 1 (Excellent) Study Rundown: OSA, resulting from
The post Tirzepatide reduces obstructive sleep apnea symptoms and associated risks first appeared on 2 Minute Medicine. Source: 2 Minute Medicine
‘My cancer was not in those pictures’: how breast density affects mammograms
A new FDA rule requires that screenings inform people if they have a high ratio of dense breast tissue. Experts say it’s just one step toward awarenessIn 2017, 55-year-old Leslie Ferris Yerger underwent a routine mammogram and breast ultrasound. Both came back clear. Two months later, she had an unrelated Dexa scan to measure her bone density. The technician noticed an abnormality in her hip. After additional testing, Yerger was diagnosed with stage four breast cancer – an advanced stage of the disease in which the cancer has spread beyond the breasts.The mammogram and ultrasound had not picked up the cancer because, Yerger would learn, of her dense breast tissue. Continue reading…
Let’s Talk Breast Density; Cancer, Movies, and Music; Treatment-Induced Aging?
(MedPage Today) — As an FDA-mandated rule goes into effect requiring healthcare providers to notify women of their breast density, the American Cancer Society has an explainer on what the rule means for patients and providers.
Analysis of another…
Shop these pink products that support breast cancer charities
From the Estée Lauder Bouquet of Strength collection to Pretty in Pink PJs, lifestyle expert Chassie Post joins TODAY with a list of businesses that are giving back to breast cancer charities!
Buyer beware: Off-brand Ozempic, Zepbound and other weight loss products carry undisclosed risks for consumers
In just a few years, brand-name injectable drugs such as Ozempic, Wegovy, Mounjaro and Zepbound have rocketed to fame as billion-dollar annual sellers for weight loss as well as to control blood sugar levels and reduce the risk of heart disease.
Kathy Bates addresses Ozempic rumors after 100-pound weight loss: ‘This was hard work’
Kathy Bates credited both hard work and Ozempic medication for her diabetes diagnosis for helping her lose 100 pounds over a span of seven years.
STAT+: Medicare already covers GLP-1s for half of seniors with obesity, new report finds
Medicare is prohibited by law from covering GLP-1 drugs for weight loss. But many beneficiaries can access the drugs anyway.
Ozempic underworld: Inside the black market of obesity drugs
A CNBC investigation into counterfeit weight-loss drugs revealed an international illegal marketplace where criminals either alter the drugs or ship the real product from overseas.
Offering Wegovy and other weight loss drugs on Medicare could cost $35 billion
Allowing Medicare to cover popular weight loss drugs such as Wegovy and Zepbound could increase federal spending by billions of dollars, according to a new report by the Congressional Budget Office (CBO).Read more…